MTOR and neoplasm: Recent studies have shown that noncanonical NF-κB signaling is associated with IBN resistance (26), and PI3K/AKT/mTOR and integrin signaling also confer tumor microenvironment–driven (TME-driven) IBN resistance in MCL (27).